Ana
Moreno Álvarez
Universidade da Coruña
La Coruña, EspañaUniversidade da Coruña-ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
-
Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials
Children, Vol. 11, Núm. 3
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2022
2021
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
-
Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease
Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17
2020
-
Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease
International Journal of Molecular Sciences, Vol. 21, Núm. 9
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
2019
-
Fructose malabsorption in asymptomatic children and in patients with functional chronic abdominal pain: a prospective comparative study
European Journal of Pediatrics, Vol. 178, Núm. 9, pp. 1395-1403
2018
-
V232D mutation in patients with cystic fibrosis Not so rare, not so mild
Medicine (United States), Vol. 97, Núm. 28